{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:27:38Z","timestamp":1734586058634,"version":"3.30.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"DOI":"10.7759\/cureus.75953","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:14:17Z","timestamp":1734542057000},"source":"Crossref","is-referenced-by-count":0,"title":["A Warning Against Antibiotic Treatment for Gastrointestinal Non-Typhoidal Salmonella Infections in Immunocompetent Adults: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Elizabeth","family":"Keil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"CDC. Salmonella Infection (Salmonellosis). (2024). Accessed: September 19, 2024: https:\/\/www.cdc.gov\/salmonella\/index.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2105\/CCDM.2745.127","article-title":"Salmonellosis. Control of Communicable Diseases Manual","author":"Parry CM","unstructured":"Parry CM. Salmonellosis. Control of Communicable Diseases Manual. American Public Health Association, Washington, DC; 10.2105\/CCDM.2745.127"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00066-X","article-title":"Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial","volume":"23","author":"Brendish NJ","year":"2023","unstructured":"Brendish NJ, Beard KR, Malachira AK, et al.. Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial. Lancet Infect Dis. 2023, 23:945-55. 10.1016\/S1473-3099(23)00066-X","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2018.05.008","article-title":"Common gastrointestinal infections","volume":"45","author":"Sell J","year":"2018","unstructured":"Sell J, Dolan B. Common gastrointestinal infections. Prim Care. 2018, 45:519-32. 10.1016\/j.pop.2018.05.008","journal-title":"Prim Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-3-202","article-title":"Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group","volume":"117","author":"Wistr\u00f6m J","year":"1992","unstructured":"Wistr\u00f6m J, Jertborn M, Ekwall E, et al.. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med. 1992, 117:202-8. 10.7326\/0003-4819-117-3-202","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001167.pub2","article-title":"Antimicrobials for treating symptomatic non-typhoidal Salmonella infection","volume":"11","author":"Onwuezobe IA","year":"2012","unstructured":"Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev. 2012, 11:CD001167. 10.1002\/14651858.CD001167.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ1221","article-title":"Persistent infections by nontyphoidal Salmonella in humans: epidemiology and genetics","volume":"62","author":"Marzel A","year":"2016","unstructured":"Marzel A, Desai PT, Goren A, et al.. Persistent infections by nontyphoidal Salmonella in humans: epidemiology and genetics. Clin Infect Dis. 2016, 62:879-86. 10.1093\/cid\/civ1221","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00088-18","article-title":"Persistent infection and long-term carriage of typhoidal and nontyphoidal Salmonellae","volume":"32","author":"Gal-Mor O","year":"2018","unstructured":"Gal-Mor O. Persistent infection and long-term carriage of typhoidal and nontyphoidal Salmonellae. Clin Microbiol Rev. 2018, 32:e00088-18. 10.1128\/CMR.00088-18","journal-title":"Clin Microbiol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2023.12.001","article-title":"Persistent Salmonella infections in humans are associated with mutations in the BarA\/SirA regulatory pathway","volume":"32","author":"Grote A","year":"2024","unstructured":"Grote A, Piscon B, Manson AL, et al.. Persistent Salmonella infections in humans are associated with mutations in the BarA\/SirA regulatory pathway. Cell Host Microbe. 2024, 32:79-92.e7. 10.1016\/j.chom.2023.12.001","journal-title":"Cell Host Microbe"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00319-08","article-title":"Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection","volume":"76","author":"Sekirov I","year":"2008","unstructured":"Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun. 2008, 76:4726-36. 10.1128\/IAI.00319-08","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.000709","article-title":"Salmonella infection - prevention and treatment by antibiotics and probiotic yeasts: a review","volume":"164","author":"Gut AM","year":"2018","unstructured":"Gut AM, Vasiljevic T, Yeager T, Donkor ON. Salmonella infection - prevention and treatment by antibiotics and probiotic yeasts: a review. Microbiology (Reading). 2018, 164:1327-44. 10.1099\/mic.0.000709","journal-title":"Microbiology (Reading)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.05.513","article-title":"Treatment of Salmonellosis with Saccromyces boulardii","volume":"12","author":"Krasnov MI","year":"2008","unstructured":"Krasnov MI. Treatment of Salmonellosis with Saccromyces boulardii. Int J Infect Dis. 2008, 12:e207. 10.1016\/j.ijid.2008.05.513","journal-title":"Int J Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijfoodmicro.2007.07.042","article-title":"Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis","volume":"118","author":"Golowczyc MA","year":"2007","unstructured":"Golowczyc MA, Mobili P, Garrote GL, Abraham AG, De Antoni GL. Protective action of Lactobacillus kefir carrying S-layer protein against Salmonella enterica serovar Enteritidis. Int J Food Microbiol. 2007, 118:264-73. 10.1016\/j.ijfoodmicro.2007.07.042","journal-title":"Int J Food Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/foods10061210","article-title":"Kefir and its biological activities","volume":"10","author":"Azizi NF","year":"2021","unstructured":"Azizi NF, Kumar MR, Yeap SK, et al.. Kefir and its biological activities. Foods. 2021, 10:1210. 10.3390\/foods10061210","journal-title":"Foods"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X11428502","article-title":"Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders","volume":"5","author":"Kelesidis T","year":"2012","unstructured":"Kelesidis T, Pothoulakis C. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012, 5:111-25. 10.1177\/1756283X11428502","journal-title":"Therap Adv Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11040896","article-title":"Lactobacillus bacteremia and probiotics: a review","volume":"11","author":"Kullar R","year":"2023","unstructured":"Kullar R, Goldstein EJ, Johnson S, McFarland LV. Lactobacillus bacteremia and probiotics: a review. Microorganisms. 2023, 11:896. 10.3390\/microorganisms11040896","journal-title":"Microorganisms"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316004-a-warning-against-antibiotic-treatment-for-gastrointestinal-non-typhoidal-salmonella-infections-in-immunocompetent-adults-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T17:14:22Z","timestamp":1734542062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316004-a-warning-against-antibiotic-treatment-for-gastrointestinal-non-typhoidal-salmonella-infections-in-immunocompetent-adults-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.75953","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}